BIOXYTRAN, INC. Share-based Payment Arrangement, Expense
BIOXYTRAN, INC. (BIXT) reported Share-based Payment Arrangement, Expense of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- BIOXYTRAN, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $7.82K, a 81.42% decline year-over-year.
- BIOXYTRAN, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.29M, a 4678.19% increase year-over-year.
- BIOXYTRAN, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $84.57K, a 63.10% decline year-over-year.
- BIOXYTRAN, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $43.74K, a 12.53% increase year-over-year.
- BIOXYTRAN, INC. share-based payment arrangement, expense for fiscal 2025 was $197.38K, a 68.87% decline from fiscal 2024.
- BIOXYTRAN, INC. share-based payment arrangement, expense for fiscal 2024 was $634.02K, a 257.36% increase from fiscal 2023.
- BIOXYTRAN, INC. share-based payment arrangement, expense for fiscal 2023 was $177.42K, a 0.54% decline from fiscal 2022.
- BIOXYTRAN, INC. share-based payment arrangement, expense for fiscal 2022 was $178.38K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.30M 10-Q · filed 2026-08-14 | $1.38M derived: sum of 3 quarters · filed 2026-08-14 | $1.43M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-15 | $1.37M derived: sum of 2 quarters · filed 2026-05-15 | $1.42M derived: sum of 3 quarters · filed 2026-05-15 | $1.46M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $84.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $128.31K derived: sum of 2 quarters · filed 2026-04-15 | $170.38K derived: sum of 3 quarters · filed 2026-08-14 | $197.38K 10-K · filed 2026-04-15 | ||
| 2025-09-30 | $43.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $85.80K derived: sum of 2 quarters · filed 2026-08-14 | $112.80K 10-Q · filed 2025-11-14 | $342.02K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $42.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $69.06K 10-Q · filed 2026-08-14 | $298.28K derived: sum of 3 quarters · filed 2026-08-14 | $337.15K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-15 | $28.60K 10-Q · filed 2025-05-15 | $256.22K derived: sum of 2 quarters · filed 2026-05-15 | $295.09K derived: sum of 3 quarters · filed 2026-05-15 | $360.78K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $229.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $268.09K derived: sum of 2 quarters · filed 2026-04-15 | $333.78K derived: sum of 3 quarters · filed 2026-04-15 | $634.02K 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $38.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $104.56K derived: sum of 2 quarters · filed 2025-11-14 | $404.81K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $65.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $365.94K 10-Q · filed 2025-08-11 | ||||
| 2024-03-31 | $300.25K 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | $177.42K 10-K · filed 2025-04-03 | $176.45K 10-K/A · filed 2025-01-13 | ||||
| 2022-12-31 | $178.38K 10-K/A · filed 2025-01-13 |